Proposed Changes to U.S. Policy on Potential Pandemic Pathogen Oversight and Implementation | Zendy

Thomas V. Inglesby | Zendy; Marc Lipsitch | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Proposed Changes to U.S. Policy on Potential Pandemic Pathogen Oversight and Implementation

Author(s) -

Thomas V. Inglesby,

Marc Lipsitch

Publication year - 2020

Publication title -

msphere

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.749

H-Index - 39

ISSN - 2379-5042

DOI - 10.1128/msphere.00990-19

Subject(s) - biosecurity , biosafety , transparency (behavior) , government (linguistics) , pandemic , work (physics) , covid-19 , political science , public administration , business , public relations , infectious disease (medical specialty) , medicine , engineering , biology , law , disease , microbiology and biotechnology , mechanical engineering , linguistics , philosophy , pathology

We propose here changes to the U.S. government policy on potential pandemic pathogen (PPP) oversight and implementation, emphasizing transparency of the review process and the content of the review, publication of the review in advance, responsible publication of enhanced PPP research, high-level signoff on approvals of enhanced PPP experiments, and the need for a significant effort to establish a common international approach to enhanced PPP work. We advocate that the U.S. government recommend, and non-U.S. government funders and journals adopt, a set of best practices that would extend important considerations of biosafety and biosecurity to all work on enhanced potential pandemic pathogens regardless of funding source.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research